MarketPulse

clinical trial protocol

2 articles
GlobeNewswire Inc.GlobeNewswire Inc.··Bronstein, Gewirtz & Grossman Llc

Nektar Therapeutics Faces Class Action Over Misleading Trial Statements

Class action lawsuit filed against Nektar Therapeutics alleging executives made false statements about REZOLVE-AA trial enrollment, claiming protocol violations negatively impacted results.
NKTRsecurities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··Na

Nektar Therapeutics Faces Class Action Over Misleading Trial Data Claims

Class action lawsuit filed against $NKTX alleging executives made false statements about REZOLVE-AA trial enrollment protocols, potentially harming investor value.
NKTRsecurities fraudclass action lawsuit